m6A Target Gene Information
General Information of the m6A Target Gene (ID: M6ATAR00398)
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
SMURF1
can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Disease
Methyltransferase-like 3 (METTL3) [WRITER]
Representative RNA-seq result indicating the expression of this target gene regulated by METTL3 | ||
Cell Line | HeLa cell line | Homo sapiens |
Treatment: METTL3 knockdown HeLa cells
Control: HeLa cells
|
GSE70061 | |
Regulation |
|
logFC: -1.08E+00 p-value: 3.04E-03 |
More Results | Click to View More RNA-seq Results |
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
Response Summary | METTL3 knockdown inhibits osteoblast differentiation and Smad-dependent signaling by stabilizing Smad7 and E3 ubiquitin-protein ligase SMURF1 (SMURF1) mRNA transcripts via YTHDF2 involvement and activates the inflammatory response by regulating MAPK signaling in LPS-induced inflammation. | |||
Target Regulation | Down regulation | |||
Responsed Disease | Inflammatory response | ICD-11: MG46 | ||
Pathway Response | MAPK signaling pathway | hsa04010 | ||
Cell Process | RNA stability | |||
In-vitro Model | MC3T3-E1 | Normal | Mus musculus | CVCL_0409 |
YTH domain-containing family protein 2 (YTHDF2) [READER]
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
Response Summary | METTL3 knockdown inhibits osteoblast differentiation and Smad-dependent signaling by stabilizing Smad7 and E3 ubiquitin-protein ligase SMURF1 (SMURF1) mRNA transcripts via YTHDF2 involvement and activates the inflammatory response by regulating MAPK signaling in LPS-induced inflammation. | |||
Target Regulation | Down regulation | |||
Responsed Disease | Inflammatory response | ICD-11: MG46 | ||
Pathway Response | MAPK signaling pathway | hsa04010 | ||
Cell Process | RNA stability | |||
In-vitro Model | MC3T3-E1 | Normal | Mus musculus | CVCL_0409 |
Inflammatory response [ICD-11: MG46]
In total 2 item(s) under this disease | ||||
Experiment 1 Reporting the m6A-centered Disease Response | [1] | |||
Response Summary | METTL3 knockdown inhibits osteoblast differentiation and Smad-dependent signaling by stabilizing Smad7 and E3 ubiquitin-protein ligase SMURF1 (SMURF1) mRNA transcripts via YTHDF2 involvement and activates the inflammatory response by regulating MAPK signaling in LPS-induced inflammation. | |||
Responsed Disease | Inflammatory response [ICD-11: MG46] | |||
Target Regulator | Methyltransferase-like 3 (METTL3) | WRITER | ||
Target Regulation | Down regulation | |||
Pathway Response | MAPK signaling pathway | hsa04010 | ||
Cell Process | RNA stability | |||
In-vitro Model | MC3T3-E1 | Normal | Mus musculus | CVCL_0409 |
Experiment 2 Reporting the m6A-centered Disease Response | [1] | |||
Response Summary | METTL3 knockdown inhibits osteoblast differentiation and Smad-dependent signaling by stabilizing Smad7 and E3 ubiquitin-protein ligase SMURF1 (SMURF1) mRNA transcripts via YTHDF2 involvement and activates the inflammatory response by regulating MAPK signaling in LPS-induced inflammation. | |||
Responsed Disease | Inflammatory response [ICD-11: MG46] | |||
Target Regulator | YTH domain-containing family protein 2 (YTHDF2) | READER | ||
Target Regulation | Down regulation | |||
Pathway Response | MAPK signaling pathway | hsa04010 | ||
Cell Process | RNA stability | |||
In-vitro Model | MC3T3-E1 | Normal | Mus musculus | CVCL_0409 |